Pacira BioSciences, Inc.

NASDAQ (USD): Pacira BioSciences, Inc. (PCRX)

Last Price

26.24

Today's Change

+0.21 (0.80%)

Day's Change

25.67 - 27.59

Trading Volume

953,421

Overview

Market Cap

1 Billion

Shares Outstanding

46 Million

Avg Volume

785,661

Avg Price (50 Days)

19.63

Avg Price (200 Days)

20.74

PE Ratio

-13.25

EPS

-1.98

Earnings Announcement

26-Feb-2025

Previous Close

26.03

Open

27.00

Day's Range

25.67 - 27.59

Year Range

11.16 - 32.65

Trading Volume

1,000,175

Price Change Highlight

1 Day Change

0.81%

5 Day Change

12.33%

1 Month Change

39.28%

3 Month Change

58.07%

6 Month Change

27.07%

Ytd Change

43.15%

1 Year Change

-19.48%

3 Year Change

-58.20%

5 Year Change

-39.29%

10 Year Change

-75.97%

Max Change

273.79%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment